Judith Gonzales
Psychiatric/Mental Health · Johnston, IANPI 1164725339
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 538 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 17.6% — the pattern of someone who eats at a lot of different presentations. Among psychiatric/mental health clinicians in IA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 538 payments — averaging $21.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Johnson & Johnson$2K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
- Otsuka America Pharmaceutical, Inc.$968
- Alkermes, Inc.$874
- Lundbeck LLC$838
- plus $4K from 23 others
What the payments were for
- Food & beverage$11,754100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 92 | $2,065 |
| Johnson & Johnson | 68 | $1,938 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 58 | $1,020 |
| Otsuka America Pharmaceutical, Inc. | 39 | $968 |
| Alkermes, Inc. | 23 | $874 |
| Lundbeck LLC | 58 | $838 |
| Teva Pharmaceuticals USA, Inc. | 38 | $587 |
| Axsome Therapeutics, Inc. | 25 | $531 |
| Almatica Pharma LLC | 35 | $506 |
| Corium, LLC | 14 | $369 |
| Takeda Pharmaceuticals U.S.A., Inc. | 19 | $318 |
| E.r. Squibb & Sons, L.L.C. | 8 | $280 |
| Vanda Pharmaceuticals Inc. | 3 | $264 |
| Tris Pharma Inc | 11 | $218 |
| Novo Nordisk | 6 | $207 |
| Supernus Pharmaceuticals, Inc. | 7 | $149 |
| Jazz Pharmaceuticals Inc. | 6 | $121 |
| Neos Therapeutics, LP | 5 | $84 |
| Idorsia Pharmaceuticals US Inc | 4 | $76 |
| Ironshore Pharmaceuticals Inc. | 4 | $66 |
| Neurocrine Biosciences, Inc. | 3 | $55 |
| Sunovion Pharmaceuticals Inc. | 3 | $53 |
| MDD US Operations, LLC | 2 | $43 |
| Eisai Inc. | 2 | $31 |
| Lilly USA, LLC | 1 | $25 |
| Bausch Health US, LLC | 1 | $17 |
| Collegium Pharmaceutical, Inc. | 1 | $17 |
| Itamar Medical Inc | 1 | $17 |
| Adlon Therapeutics L.p. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYBALVI$1,359
- SPRAVATO$816
- REXULTI$463
- ARISTADA$462
- CAPLYTA$250
- Fanapt$250
- VRAYLAR$244
- INVEGA SUSTENNA$150
- Azstarys$129
- Quillichew ER$125
- Dyanavel XR$125
- Quillivant$125
- Wegovy$124
- Auvelity$122
- COBENFY$122
- ARISTADA INITIO$115
- UZEDY$111
How this compares
$11,754 in reported general payments places this provider in the 95th percentile of 443 psychiatric/mental health providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FetzimaLevomilnacipran Hcl | 22 | $16,010 |
| Lurasidone Hcl | 42 | $13,415 |
| Methylphenidate ErMethylphenidate Hcl | 14 | $4,309 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 30 | $2,400 |
| Bupropion XlBupropion Hcl | 69 | $2,128 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 19 | $787 |
| Duloxetine Hcl | 29 | $739 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 32 | $717 |
| Clonazepam | 89 | $646 |
| Zolpidem Tartrate ErZolpidem Tartrate | 22 | $612 |
| Fluoxetine Hcl | 19 | $518 |
| Trazodone Hcl | 62 | $493 |
| Prazosin Hcl | 11 | $489 |
| Lamotrigine | 30 | $464 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 33 | $461 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieFetzima | $2,065 | $16,01022 claims |
| Lilly USA, LLCOlanzapine | $25 | $32521 claims |
| Almatica Pharma LLCSertraline Hcl | $506 | $4614 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 443 psychiatric/mental health providers in Iowa.
Other psychiatric/mental health in Johnston
- Erin Fox-HammelJohnston$5K
- Lorraine ChidesterJohnston$5K
- Tarrah HollidayAtlantic$421K
- Kelsie SwisherParkersburg$235K
- Jennifer BradleyCedar Rapids$66K
- Kama AusbornWaterloo$64K
- Quentin ChambersDes Moines$40K
- Tenaea JeppesonFort Dodge$38K
- Jennifer WittmanCoralville$25K
- Amy MorinCedar Rapids$24K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.